Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2006-04-11
2006-04-11
Schwadron, Ronald B. (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S139100, C424S143100, C424S144100, C424S154100, C424S156100, C424S173100, C435S975000, C530S388220, C530S388700, C530S388750, C530S388850, C530S387700, C530S389600, C530S350000, C530S391100, C530S387300, C530S387900, C530S391300
Reexamination Certificate
active
07025962
ABSTRACT:
Purified genes encoding a T cell surface antigen from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this antigen are provided. Methods of using said reagents and diagnostic kits are also provided.
REFERENCES:
patent: 5457035 (1995-10-01), Baum et al.
patent: 5709858 (1998-01-01), Godowski et al.
patent: WO 91/06644 (1991-05-01), None
patent: WO 96/15272 (1996-05-01), None
Richard J. Armitage, et al.,Nature, 357: 80-82, 1992. “Molecular and biological characterization of a murine ligand for CD40”.
Charles Auffray, et al., C.R. Acad. Sci. Paris, 318(2):263-272, 1995. “IMAGE: molecular integration of the analysis of the human genome and its expression”.
C. Auffray, et al.,GenBank, Accession No. F09449, Sep. 21, 1995. “IMAGE: molecular integration of the analysis of the human genome and its expression”.
Peter R. Baum, et al., Circulator Shock, 44(1):30-34, 1994. “Identification of OX40 Ligand and Preliminary Characterization of Its Activities on OX40 Receptor”.
P.R. Baum, et al.,GenBank, Entrez Protein Query, GenPept Report, Accession No. 1252423, Oct. 12, 1995. “Cytokine which is a ligand for OX40”.
P.R. Baum, et al.,GenBank, Accession No. S76792, Jul. 26, 1995. “Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor”.
G.I. Bell,GenBank, Accession No. Z11899, Jun. 4, 1996. DEFINITION:H. sapiensOTF3 mRNA encoding octomer-binding protein 3B.
G.I. Bell,GenBank, Accession No. Z11901, Jun. 25, 1997. DEFINITION:H. sapiensOTF3 gene encoding octomer binding protein 3-like sequence.
Barbara E. Bierer, et al.,Semin. Immunol., 5: 249-261, (1993). “T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2”.
Marion L. Birkeland, et al.,Eur. J. Immunol., 25(4):926-930, 1995. “Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein”.
M.L. Birkeland, et al.,GenBank, Accession No. X85214, Aug. 23, 1995. “Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein”.
David M. Calderhead, et al.,J. Immunol., 151(10)5261-5271, 1993. “Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions”.
D.M. Calderhead, et al.,GenBank, Accession No. Z21674, Dec. 20, 1993. “Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions”.
Benjamin G. Cocks, et al.,Int. Immunol., 5(6): 657-663, (1993). “IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand”.
Benjamin G. Cocks, et al.,Nature, 376: 260-263, (1995). “A novel receptor involved in T-cell activation”.
Jonathan M. Green, et al.,Immunity, 1: 501-508, (1994). “Absence of B7-Dependent Responses in CD28-Deficient Mice”.
Marc K. Jenkins, et al.,Curr. Opin. Immunol., 5: 361-367, (1993). “Molecules involved in T-cell costimulation”.
Marc K. Jenkins,Immunity, 1: 443-446, (1994). “The Ups and Downs of T cell Costimulation”.
Carl H. June, et al.,Immunol. Today, 11(6):211-216, (1990). “Role of the CD28 receptor in T-cell activation”.
Gregory S. Kelner , et al.,Science, 266:1395-1399, Nov. 25, 1994. “Lymphotactin: A New Cytokine That Represents a New Class of Chemokine”.
Matthew F. Krummel, et al.,J. Exp. Med., 182: 459-465, (1995). “CD28 and CTLA-4 Have Opposing Effects on the Response of T cells to Simulation”.
Ute Latza, et al.,Eur. J. Immunol., 24(3):677-683, 1994. “The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen”.
U. Latza, et al.,GenBank, Accession No. X75962, May 13, 1994. “The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen”.
Matoba, R, et al.,Gene, 146:199-207, Dec. 1994 The addition of 5′—coding information to a 3′—directed cDNA library improves analysis of gene expression.
Matoba, R. et al. ,GenBank, Accession No. D17247, Dec. 1, 1994.
M. Marra, et al.,GenBank, Accession No. AA023897, Jan. 21, 1997. “The WashU-HHMI Mouse EST Project”.
M. Marra, et al.,GenBank, Accession No. W98639, Jul. 16, 1996. “The WashU-HHMI Mouse EST Project”.
T. Newman, et al.,EMBL Sequence Database, Accession No. T22298, Jun. 27, 1994. “Genes galore: a summary of methods for accessing results from large-scale partial sequencing of anonymousArabidopsiscDNA clones”.
Christine A. Power and Timothy N.C. Wells,TIPS, 17(6):209-213, Jun. 1996. “Cloning and characterization of human chemokine receptors”.
Franca Ronchese, et al.,J. Exp. Med., 179: 809-817, (1994). “Mice Transgenic for a Soluble Form of Murine CTLA-4 Show Enhanced Expansion of Antigen-specific CD4+T Cells and Defective Antibody Production In Vivo”.
Eric Rouvier, et al.,J. Immunol., 150(12): 5445-5456, (1993). “CTLA-8, Cloned from an Activated T Cell, Bearing AU-Rich Messenger RNA Instability Sequences, and Homologous to a Herpes virus Saimiri Gene1”.
Meenakshi Roy, et al.,Eur. J. Immunol., 25: 596-603, (1995). “Studies on the interdependence on gp39 and B7 expression and function during antigen-specific immune responses”.
A. Ruehlmann, et al.,EMBL Sequence Database, Accession No. X75316, Oct. 12, 1993. “A novel murine RRM-type protein and its human homologue”.
Joseph Sambrook, et al.,Molecular Cloning, A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, 1989, pp. 11.2, and 17.2-17.29.
Arda Shahinian, et al.,Science, 261: 609-612, (1993). “Differential T Cell Costimulatory Requirements in CD28-Deficient Mice”.
Jun Takeda, et al.,Nucleic Acids Research, 20(17):4613-4620, 1992. “Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues”.
J. Takeda, et al.,GenBank, Accession No. Z11898, Sep. 28, 1992. “Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues”.
J. Takeda, et al.,GenBank, Accession No. Z11900, Jun. 25, 1997. “Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression in adult tissues”.
E.A. Telford, et al.,EMBL Sequence Database, Accession No. U20824, May 4, 1995. “The DNA sequence of equine herpes virus 2”.
Eva Wey, et al.,Eur. J. Biochem., 220(3):753-762, 1994. “A human POU dornain gene, mPOU, is expressed in developing brain and specific adult tissues”.
E. Wey, et al.,GenBank, Accession No. Z21963, Jun. 27, 1994. “A human POU domain gene, mPOU, is expressed in developing brain and specific adult tissues”.
E. Wey, et al.,GenBank, Accession No. Z21964, Jun. 27, 1994. “mPOU: A novel human POU domain gene expressed in specific adult tissues”.
Gorman Daniel M.
Randall Troy D.
Zlotnik Albert
Ching Edwin P.
Hill Laurie L.
Schering Corporation
Schwadron Ronald B.
LandOfFree
Mammalian cell surface antigens; related reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian cell surface antigens; related reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian cell surface antigens; related reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3524454